Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
acute disseminated encephalomyelitis
acute disseminated encephalomyelitis, multiphasic
adenylate kinase 5 autoantibodies
advances in neurology
afebrile
affect, flat
aggression
agitation
alternative medicine
alveolar hypoventilation
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amnesia
amnesia, anterograde
amygdala
amygdalohippocampectomy
amyloid beta protein
amyloid imaging
amyloid plaques
ANA
anatomy of
angiography, cerebral
anti Hu antibody
anti Ro antibody
anticonvulsants
anticonvulsants, effectiveness
anticonvulsants, selection of
anticonvulsants, untoward effects of
antiviral agents
anxiety
aphasia
apolipoprotein E
arrhythmia, cardiac
arteriovenous malformation
arteriovenous malformation, cerebral
astrocytoma
asymptomatic
ataxia
ataxia, cerebellar
atypical
aura
autism
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
autoimmune GFAP astrocytopathy
automatisms
autonomic dysfunction
B cell lymphoma
Babinski sign
barbiturate anesthesia
basal ganglia
basal ganglia, lesion of
behavior
behavior, combative
behavioral disorder
biologic markers
blindness
blindness, sudden
brain atrophy
brain biopsy
brain volume
brainstem, lesion of
burst suppression pattern, electroencephalogram
carcinoma
carcinoma of lung
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
CAT scan, metrizamide
cavernous hemangioma
CD19-directed chimeric antigen receptor T-cell therapy
central nervous system, infection of
cerebellar lesion
cerebellar pontine angle
cerebellar pontine angle tumor
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortex
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebral hemisphere left-right asymmetry
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
chemotherapy, CNS treatment and complications with
children
Clinical Pathologic Conference(C.P.C.)
cognition
coma
coma, medically induced
complications
confusion
confusional state, acute
corpus callosotomy
corpus callosum
corpus callosum, lesion of
cortical dysplasia, focal
cortical resection
cost effectiveness
cytokine release syndrome
cytomegalovirus infection
deep gray nuclei
degenerative diseases of CNS
delusion
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, frontotemporal
dementia, rapidly progressive
dementia, screening for
demyelinating disease
diagnostic criteria
diarrhea
diet
differential diagnosis
diplopia
disability, neurological
disorientation
drowsiness
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, video monitoring with
encephalitis
encephalitis, autoimmune
encephalitis, focal
encephalitis, unknown etiology
encephalitis, viral
encephalomalacia
encephalomyelitis
encephalopathy
encephalopathy, acute
encephalopathy, limbic
encephalopathy, post traumatic
epilepsy
epilepsy monitoring unit
epileptic encephalopathy
episodic disorders
episodic neurologic deficits
eye movement, disorders of
face, numbness of
facial asymmetry
facial weakness
familial
febrile infection-related epilepsy syndrome
fever
flu-like illness
fragile-X syndrome
gammaglobulin therapy, intravenous
gender
Geschwind, Norman
GFAP-IgG
glioma
gliomatosis cerebri
gliosis
glutamic acid decarboxylase, antibody
glyphosate
gray matter
hallucination
hallucination, auditory
hamartoma
head injury
head injury, prognosis in
headache
headache, recurrent
hemimyoclonic jerks
hemiparesis
hemispherectomy
heralding manifestation
herbicide
herpes simplex encephalitis
hiccoughs
hippocampal atrophy
hippocampus
hippocampus, hyperintense
histopathology
human herpesvirus 6
hyperactivity
hypersomnia
hyponatremia
hypothalamus, lesion of
hypothyroidism
immune effector cell-associated neurotoxicity syndrome
immune-related adverse events
immunohistochemistry
immunologic disease
immunosuppression
immunosuppressive agents
immunotherapy
inattention
incidentaloma
inclusion bodies
inclusion bodies, intracytopasmic
infection
insular cortex
insular cortex, lesion
insular cortex, lesion, bilateral
intellectual deficit
intellectual deterioration
ketogenic diet
learning disability
learning disability, in children
lethargy
leucine rich glioma inactivated 1 antibodies
leukopenia
level of consciousness
level of consciousness, decreased
limbic encephalitis
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lobar atrophy
lymphadenopathy, hilar
lymphoma
lymphoma, systemic
malformation, vascular
malformation, vascular, cerebral
malignancy screen
memory, defect of recent
memory, evaluation of
memory, impairment of
meningeal enhancement
meningioma
meningitis
meningitis, neurologic aspects and complications of
meningitis, seizures with
meningoencephalomyelitis
mental retardation
mesial temporal lobe
mesial temporal lobe epilepsy
mesial temporal sclerosis
mesial temporal sclerosis, bilateral
microhemorrhage, intracerebral
microinfarcts
midbrain, lesion of
middle cerebellar peduncle, lesion
mild cognitive impairment
mimics
misdiagnosis
mitochondrial disease
mortality
movement disorder
MRI
MRI pattern
MRI, abnormal
MRI, abnormal, seizure causing
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, false negative
MRI, field strength, high
MRI, FLAIR
MRI, functional
MRI, gyral enhancement
MRI, head injury
MRI, incidental finding
MRI, indications for
MRI, morphometyry
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRI, spinal cord
MRI, volumetry
MRI, voxel-based morphometry
MRS
multiple sclerosis
multiple sclerosis, misdiagnosis
multiple subpial transection
myelitis, longitudinal
myoclonic jerks
myoclonus
negative
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuronal migration disorder
neuropathology
neuropathology, brain
neuropathy
neurosyphilis
neurotoxin
NMDA antagonists
NMDA receptors
normal
nystagmus
nystagmus, primary position of gaze
ocular dipping
old age, neurology of
optic chiasm
optic chiasm, lesion of
pain
pain, leg
pallor
paranoia
Parkinsonism syndrome
periaqueductal lesion
perseveration
personality change
personality disorder
plasmapheresis
PLEDs
PLEDs, bilateral independent
PLEDs, etiology of
pleocytosis of cerebrospinal fluid
posterior fossa, lesion of
postictal neurologic deficits
postictal psychosis
potassium channel antibodies
precipitating factors
preclinical
prevention of neurologic disorders
prognosis
progressive neurologic disorder
prosopagnosia
psychiatric problems in neurologic disorders
psychological testing
psychosis
psychosurgery
psychotic behavior
pulmonary nodules
quadrantanopsia, superior
quadriparesis
rapidly progressing neurologic illness
recurrent
release phenomena
religiosity
remote effect of cancer on the nervous system
reversible neurologic disorder
review article
rheumatoid arthritis factor(R.A.factor)
risk factors
salivation, excessive
schizophrenia
screening
sedimentation rate, elevated
seizure
seizure, adult onset
seizure, children
seizure, classification of
seizure, complications following
seizure, diagnosis of
seizure, drug resistance
seizure, elderly
seizure, equivalents
seizure, etiology of
seizure, febrile
seizure, febrile, risk of epilepsy following
seizure, focal
seizure, focus
seizure, intractable
seizure, intractable, treatment of
seizure, medication failure
seizure, new onset
seizure, prevention of
seizure, prognosis in adults
seizure, prognosis in childhood
seizure, psychomotor-frontal lobe
seizure, psychomotor-temporal lobe
seizure, psychomotor-temporal lobe, interictal behavior
seizure, psychomotor-temporal lobe, prognosis of
seizure, psychosocial aspects of
seizure, recurrent
seizure, risk factors for
seizure, surgical treatment of
seizure, treatment of
seizure, treatment of, polytherapy
seizure, treatment, adjunctive therapy
seizure, workup of
serologic testing
serologic testing of cerebrospinal fluid
seronegative
sexual behavior, disorder of
single photon emission computed tomography
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
sleep
small vessel disease
speech disorder
speech, slowed
standing difficulty
stare
status epilepticus
status epilepticus, intractable
steroid therapy, CNS treatment and complications with
stimulation, deep brain
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
subacute sclerosing panencephalitis, adult onset
subinsular cortex
symmetric brain lesions
syphilis, diagnosis and treatment
syphilis, neurologic complications with
tau protein
TDP-43 proteinopathy
temporal horn, enlarged
temporal lobe
temporal lobe, anatomy and physiology
temporal lobe, atrophy
temporal lobe, lesion
temporal lobe, lesion, bilateral
temporal lobe, status
temporal lobe, tumor
temporal lobectomy
temporal lobectomy, complications
teratoma
teratoma, ovarian
thalamus, lesion of
thyroid function tests
thyroiditis
tonic spasms
toxic encephalopathy
transient neurologic deficit
treatment of neurologic disorder
tremor
tuberous sclerosis
vaccination, neurologic complications with
vagus nerve stimulation
vasculopathy
ventricular enlargement
violent behavior
viral infection, CNS
visual field defect
visual loss
visual loss, sudden
water channel antibodies
weight loss
whistling
white matter disease
word-finding difficulty
workup
Showing articles 1050 to 1100 of 3668 << Previous Next >>

Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
Arch Neurol 66:1345-1352, Moraal,B.,et al, 2009

Pathologic and Immunologic Profiles of a Limited Form of Neuromyelitis Optica with Myelitis
Neurol 73:1628-1637, Yanagawa,K.,et al, 2009

Reversible Cerebral Vasoconstriction Syndrome
Pract Neurol 9:256-267, Ducros,A. &Bousser,M.-G., 2009

Effect of Glatiramer Acetate on Conversion to Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndrome (PreCISe study): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 374:1503-1511, 1475, Martinelli,G.,et al, 2009

Oral Fingolimod (FTY720) in Multiple Sclerosis: Two-Year Results of a Phase II Extension Study
Neurol 72:73-79, OConnor,P.,et al, 2009

Relapse Management in Multiple Sclerosis
The Neurologist 15:1-5, Thrower,B.W., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Early MRI in Optic Neuritis: The Risk for Disability
Neurol 72:542-550, Swanton,.K.,et al, 2009

Neuromyelitis Optica and Concentric Rings of Bal� in the Brainstem
Arch Neurol 66:274-275, Graber,J.J.,et al, 2009

A Multicenter, Prospective Pilot Study of Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy: Seizure Response, Adverse Events, and Verbal Memory
Ann Neurol 65:167-175, Barbaro,N.M.,et al, 2009

Neurosarcoidosis: A Study of 30 New Cases
JNNP 80:297-304, Joseph,F.G. &Scolding,N.J., 2009

Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy
NEJM 361:1349-1358, Azzopardi,D.,et al, 2009

The Present Efficacy of Multiple Sclerosis Therapeutics
Neurol 73:984-990, Klawiter,E.,et al, 2009

Severe Cardiac Failure in a Patient with Multiple Sclerosis Following Low-Dose Mitoxantrone Treatment
Neurol 73:991-993, D�rr,J.,et al, 2009

Exclusive Breastfeeding and the Risk of Postpartum Relapses in Women with Multiple Sclerosis
Arch Neurol 66:958-963, Langer-Gould,A.,et al, 2009

Smoking Is Associated with Increased Lesion Volumes and Brain Atrophy in Multiple Sclerosis
Neurol 73:504-510, Zivadinov,R.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Real-Life Impact of Early Interferon� Therapy in Relapsing Multiple Sclerosis
Ann Neurol 66:513-520, Trojano,M.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Practice Parameter Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Drug, Nutritional, and Respiratory Therapies (An Evidence-Based Review)
Neurol 73:1218-1226, Miller,R.G.,et al, 2009

A 52-Year-Old Woman With Disabling Peripheral Neuropathy: Review of Diabetic Polyneuropathy
JAMA 302:1451-1458, Rutkove,S., 2009

Incidental MRI Anomalies Suggestive of Multiple Sclerosis: The Radiologically Isolated Syndrome
Neurol 72:800-805,780, Okuda,D.T.,et al, 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

Pediatric Optic Neuritis: Brain MRI Abnormalities and Risk of Multiple Sclerosis
Neurol 72:881-885, Bonhomme,G.R.,et al, 2009

Hepatitis B Vaccine and the Risk of CNS Inflammatory Demyelination in Childhood
Neurol 72:873-880,870, Mikaeloff,Y.,et al, 2009

Sustained-Release Oral Fampridine in Multiple Sclerosis: A Randomised, Double-Blind, Controlled Trial
Lancet 373:732-738, Goodman,A.D.,et al, 2009

NMO-IgG Detected in CSF in Seronegative Neuromyelitis Optica
Neurol 72:1101-1003, Klawiter,E.C.,et al, 2009

MRI in the Diagnosis of Pediatric Multiple Sclerosis
Neurol 72:961-967, Callen,D.J.A.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Cortical Lesions in Primary Progressive Multiple Sclerosis: A 2-Year Longitudinal MR Study
Neurol 72:1330-1336, Calabrese,M.,et al, 2009

Memantine Induces Reversible Neurologic Impairment in Patients with MS
Neurol 72:1630-1633, Villoslada,P.,et al, 2009

MRI Features of Benign Multiple Sclerosis: Toward a New Definition of This Disease Phenotype
Neurol 72:1693-1701, Rovaris,M.,et al, 2009

A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
Arch Neurol 66:587-592, Rovira,A.,et al, 2009

Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis
Arch Neurol 66:601-609, Seewann,A.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Hippocampal Lesion Patterns in Acute Posterior Cerebral Artery Stroke: Clinical and MRI Findings
Stroke 40:2042-2045, Szabo,K.,et al, 2009

Strokes at Time of Disease Diagnosis in a Series of 287 Patients with Biopsy-Proven Giant Cell Arteritis
Medicine 88:227-235, Gonzalez-Gay,M.A.,et al, 2009

Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-Up of 70 Patients
Arch Neurol 66:841-846, Lebrun,C.,et al, 2009

A Large-Scale International Meta-Analysis of Paraoxonase Gene Polymorphisms in Sporadic ALS
Neurol 73:16-24,11, Wills,A.-M.,et al, 2009

Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
Neurol 72:2076-2082,2064, Makhani,N.,et al, 2009

Efficacy of Treatment of MS with IFN B-1b or Glatiramer Acetate by Monthly Brain MRI in the BECOME Study
Neurol 72:1976-1983,1972, Cadavid,D.,et al, 2009

Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008

Sporadic Adult-Onset Leukoencephalopathy with Neuroaxonal Spheroids Mimicking Cerebral MS
Neurol 70:1128-1133, Keegan,B.M.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Clinicopath Conf, Giant-Cell Arteritis
NEJM 359:2267-2278,1153, Case 36-2008, 2008

Picturing Multiple Sclerosis: Conventional and Diffusion Tensor Imaging
Semin Neurol 28:453-466, Fox,R.J., 2008



Showing articles 1050 to 1100 of 3668 << Previous Next >>